IndustrialConnect360

Andrew Murphy, PhD

Executive Vice President, Research

Company

Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.

regeneron.com

Other leaders at Regeneron Pharmaceuticals

wpChatIcon
wpChatIcon